Cyclo Therapeutics Inc (CYTH)
0.70
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 09:41
Cyclo Therapeutics Max Drawdown (5Y): 99.36% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.36% |
| September 30, 2024 | 99.36% |
| August 31, 2024 | 99.36% |
| July 31, 2024 | 99.36% |
| June 30, 2024 | 99.36% |
| May 31, 2024 | 99.36% |
| April 30, 2024 | 99.36% |
| March 31, 2024 | 99.36% |
| February 29, 2024 | 99.36% |
| January 31, 2024 | 99.36% |
| December 31, 2023 | 99.36% |
| November 30, 2023 | 99.36% |
| October 31, 2023 | 99.36% |
| September 30, 2023 | 99.36% |
| August 31, 2023 | 99.36% |
| July 31, 2023 | 99.36% |
| June 30, 2023 | 99.36% |
| May 31, 2023 | 99.36% |
| April 30, 2023 | 99.36% |
| March 31, 2023 | 99.22% |
| February 28, 2023 | 99.10% |
| January 31, 2023 | 99.10% |
| December 31, 2022 | 99.10% |
| November 30, 2022 | 99.10% |
| October 31, 2022 | 98.38% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.38% |
| August 31, 2022 | 98.24% |
| July 31, 2022 | 98.23% |
| June 30, 2022 | 98.12% |
| May 31, 2022 | 98.11% |
| April 30, 2022 | 97.50% |
| March 31, 2022 | 97.50% |
| February 28, 2022 | 96.98% |
| January 31, 2022 | 96.70% |
| December 31, 2021 | 96.70% |
| November 30, 2021 | 96.33% |
| October 31, 2021 | 96.33% |
| September 30, 2021 | 96.33% |
| August 31, 2021 | 96.33% |
| July 31, 2021 | 96.33% |
| June 30, 2021 | 96.33% |
| May 31, 2021 | 96.33% |
| April 30, 2021 | 96.33% |
| March 31, 2021 | 96.33% |
| February 28, 2021 | 96.33% |
| January 31, 2021 | 96.33% |
| December 31, 2020 | 96.33% |
| November 30, 2020 | 95.71% |
| October 31, 2020 | 90.67% |
| September 30, 2020 | 90.67% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
84.76%
Minimum
Nov 2019
99.36%
Maximum
Apr 2023
96.24%
Average
97.81%
Median
Max Drawdown (5Y) Benchmarks
| Stryker Corp | 43.80% |
| Biogen Inc | 58.04% |
| Pfizer Inc | 54.78% |
| Pacira BioSciences Inc | 85.67% |
| Moderna Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -45.12 |
| Beta (5Y) | -0.3784 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 95.25% |
| Historical Sharpe Ratio (5Y) | -0.525 |
| Historical Sortino (5Y) | -1.100 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.38% |